In a Clinical Laboratory News article he coauthored, ARUP Medical Director Brian Jackson, MD, describes how the COVID-19 pandemic has expanded access to testing services and created an opportunity for clinical laboratories to build on patient-centered lab stewardship.
Sean McGary wasn’t sure what kind of career he wanted when he started at ARUP in an entry-level position. He just needed a reliable schedule with a stable company. Since then, McGary has consistently moved up into positions with more responsibility and increased pay.
Students listen as automation engineer Darby Nelson (not pictured) shows how electricity and magnets can work together to levitate samples on these rectangular movers in order to avoid any friction, which decreases wear and tear on machinery.
ARUP experts evaluated an Emergency Use Authorization assay that detects SARS-CoV-2 neutralizing antibodies such as those pictured.
ARUP is using Deep Bio’s artificial intelligence-based software in research to evaluate how use of the software may aid in detection and classification of prostate cancer cells, such as the cells pictured here.
During the pandemic, ARUP hired more people than ever before to fill positions in labs associated with COVID-19 testing. When one of these labs, the Rapid Response Lab, closed, ARUP worked with a hundred employees to help them find other jobs within the company.
A donor collection specialist at the ARUP Blood Services Donor Center in Sandy bandages a donor’s arm after she has finished donating blood. ARUP is seeking donations of O-positive and O-negative blood to help address a critical shortage.
President and Chief Medical Officer Tracy George, MD, worked with ARUP’s PharmaDX and Clinical Trials group to create the central pathology review offering used in clinical trials for AYVAKIT. The new precision therapy for advanced systemic mastocytosis recently earned approval from the U.S. Food and Drug Administration.
Adam Barker, PhD, has been named ARUP’s first chief scientific officer. He moves into the role after having spent four years as director of Research and Development.